News

Should You Be Impressed By Bristol-Myers Squibb Company's (NYSE:BMY) ROE?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article ...
PE Hub18h
Accel-KKR, Carlyle, Vistria target home care software; Bain Capital, Bristol Myers Squibb launch autoimmune biopharma biz
Rounding up five deals in the home healthcare sector, which has caught the attention of Accel-KKR, Berkshire Partners, ...
Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors
Shares of Bristol Myers Squibb Co. BMY slid 5.81% to $43.31 Thursday, on what proved to be an all-around dismal trading ...
2BMY : Bristol-Myers Squibb Unusual Options Activity For July 31
Out of all of the special options we uncovered, 26 are puts, for a total amount of $1,771,839, and 16 are calls, for a total amount of $839,064. Taking into account the Volume and Open Interest on ...
Bristol Myers Squibb and Bain Capital Form New Immunology Company
The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...
Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors
This was the stock's fifth consecutive day of losses.
TipRanks on MSN2d
Bristol-Myers Squibb’s New Study on Deucravacitinib: A Potential Game-Changer for Adolescent Psoriasis
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...